Total Payments
$6,472
2024 Payments
$1,322
Companies
32
Transactions
338
Medicare Patients
4,334
Medicare Billing
$617,182
Payment Breakdown by Category
Food & Beverage$6,269 (96.9%)
Education$202.98 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,269 | 335 | 96.9% |
| Education | $202.98 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $722.10 | 37 | $0 (2024) |
| Novo Nordisk Inc | $716.37 | 42 | $0 (2024) |
| Lilly USA, LLC | $701.83 | 37 | $0 (2024) |
| Astellas Pharma US Inc | $576.55 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $524.19 | 30 | $0 (2022) |
| GlaxoSmithKline, LLC. | $504.89 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $392.28 | 19 | $0 (2024) |
| PFIZER INC. | $364.28 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $325.62 | 18 | $0 (2023) |
| ABBVIE INC. | $266.71 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,322 | 66 | AstraZeneca Pharmaceuticals LP ($302.29) |
| 2023 | $1,258 | 60 | Novo Nordisk Inc ($183.77) |
| 2022 | $693.78 | 33 | Janssen Pharmaceuticals, Inc ($160.05) |
| 2021 | $665.99 | 35 | PFIZER INC. ($113.65) |
| 2020 | $522.26 | 30 | Lilly USA, LLC ($148.34) |
| 2019 | $646.51 | 37 | Astellas Pharma US Inc ($201.03) |
| 2018 | $621.82 | 39 | AstraZeneca Pharmaceuticals LP ($85.36) |
| 2017 | $741.23 | 38 | Janssen Pharmaceuticals, Inc ($173.35) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: PAIN | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Biological | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: Endocrinology | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 08/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: PAIN | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.34 | General |
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 993 | 2,097 | $330,318 | $120,085 |
| 2022 | 19 | 874 | 1,913 | $355,917 | $124,118 |
| 2021 | 22 | 1,193 | 2,649 | $526,190 | $197,670 |
| 2020 | 24 | 1,274 | 2,601 | $515,505 | $175,310 |
Total Patients
4,334
Total Services
9,260
Medicare Billing
$617,182
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 759 | $185,553 | $69,874 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $30,636 | $13,070 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 187 | $29,862 | $11,390 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 42 | $14,437 | $5,858 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $15,639 | $5,206 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 215 | 369 | $9,136 | $3,069 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $3,632 | $2,870 | 79.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $4,530 | $2,732 | 60.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 96 | 212 | $18,885 | $2,018 | 10.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $3,300 | $1,699 | 51.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 112 | $8,686 | $1,171 | 13.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 15 | 15 | $681.00 | $284.70 | 41.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $2,569 | $241.80 | 9.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $576.60 | $229.68 | 39.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $576.60 | $229.68 | 39.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 95 | $1,235 | $112.24 | 9.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 13 | $385.45 | $28.60 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 728 | $180,136 | $67,751 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 200 | $35,228 | $12,572 | 35.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 147 | $44,540 | $12,521 | 28.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 41 | $16,022 | $6,724 | 42.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 20 | 26 | $10,922 | $6,143 | 56.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $7,642 | $3,698 | 48.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 21 | 40 | $13,919 | $3,499 | 25.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 32 | 37 | $6,950 | $2,025 | 29.1% |
About Dr. Azeem Ahsan, DO
Dr. Azeem Ahsan, DO is a Geriatric Medicine healthcare provider based in Crest Hill, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861543985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Azeem Ahsan, DO has received a total of $6,472 in payments from pharmaceutical and medical device companies, with $1,322 received in 2024. These payments were reported across 338 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,269).
As a Medicare-enrolled provider, Ahsan has provided services to 4,334 Medicare beneficiaries, totaling 9,260 services with total Medicare billing of $617,182. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Crest Hill, IL
- Active Since 01/15/2007
- Last Updated 01/09/2008
- Taxonomy Code 207QG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861543985
Products in Payments
- XARELTO (Drug) $354.02
- BREZTRI (Drug) $306.95
- MOUNJARO (Drug) $304.78
- JARDIANCE (Drug) $289.55
- TRELEGY ELLIPTA (Drug) $242.89
- LINZESS (Drug) $238.92
- Ozempic (Drug) $236.56
- TRULICITY (Drug) $220.22
- MYRBETRIQ (Drug) $182.33
- ELIQUIS (Drug) $176.46
- INTELLIS ADAPTIVESTIM (Device) $170.43
- Rybelsus (Drug) $161.54
- FARXIGA (Drug) $157.51
- JANUVIA (Drug) $148.36
- VRAYLAR (Drug) $136.27
- AIRSUPRA (Drug) $126.45
- Victoza (Drug) $120.27
- Veozah (Drug) $109.99
- STIOLTO RESPIMAT (Drug) $97.24
- STEGLATRO (Drug) $94.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.